DOC2US, the first telemedicine provider in Malaysia, in compliance with the Ministry of Health to provide digitally signed e-prescription services, announced the launch of its proprietary system to test, record, manage and report COVID-19 cases for corporates and the public. The system provides a cost-effective, credible and convenient means to comply with guidelines set by the Ministry of International Trade & Industry (MITI) for economic sectors allowed to operate under Phase 2 of the National Recovery Plan.
RTKis is a comprehensive solution consisting of a Medical Device Authority (MDA) approved home-use RTK antigen test kit that allows users to conduct COVID-19 self-testing at home. Artificial intelligence (AI) is used on the DOC2US RTKis platform for identity verification and test process validation, as well as the validation of test results. Positive results will then be uploaded to the Public Health Laboratory Information System (SIMKA) which is synchronized with the MySejahtera app.
Dr Raymond Choy, Chief Executive Officer of DOC2US said, “The MITI guidelines require employees to be screened for COVID-19 twice prior to resumption of work and twice per week thereafter. With most businesses suffering loss of revenue due to the lockdowns, it is critical to provide a credible solution that is convenient and economical, thus enabling sectors that are allowed to operate to resume their activities while complying with the MITI guidelines.”
While the Rapid Test Kit Intelligent System for COVID-19 RTKis comprises the imperative component of a home testing kit that does not require the presence of a healthcare professional to administer, DOC2US deploys the use of AI to minimize fraud associated with any self-declaration.
Tan Aik-Keong, Chief Technology Officer of DOC2US and Chief Executive Officer of Agmo Studio Sdn Bhd who developed the backend system, said, “Our solution is comprehensive in design that it allows little to no room for fraud as users access the DOC2US RTKis platform via QR codes that is unique to each RTK antigen test kit sold under our package. Users will also need to verify their phone number, ID and validate their test process via photo taking and video recording. Our AI-powered system uses an image classification engine with machine learning to identify the test result based on the uploaded test kit photo.”
Currently, the RTKis work with Gmate Saliva Antigen Test Kits imported exclusively by CityMedics. On this, Dr Choy said, “We chose to kickstart our RTKis with Gmate’s home test kit as it is credible with 91% sensitivity accredited by the Institute for Medical Research, Malaysia, non-invasive, so easy to use that users can perform the test in the safety of their homes, and no on-site doctor is needed to carry out the tests. Nevertheless, our system is designed to work with other test kits as well.”
DOC2US’ RTKis Rapid Test Kit Intelligent System for COVID-19 is sold at RM45 per package and is available via the DOC2US hotline at 013-2862923.